Commercialization and demand risk
The company depends on converting syringe products and supply agreements into sustained customer orders.
- Scope
- Securgard and Sologard syringe lines
- Materiality
- high
Sharps Technology Inc.
Sharps Technology Inc. is a U.S.-based medical device company focused on syringe products and related drug-delivery systems. Its business includes the marketing and distribution of safety and disposable syringes, with operations tied to both domestic and international healthcare markets through its own product lines and distribution relationships.
4.02
2.25
| % | |
|---|---|
| Syringe products | 70% Safety, disposable, and prefillable syringe products sold for clinical and pharmaceutical use. |
| Medical device distribution | 20% Marketing and distribution of syringe inventory and related healthcare products to end customers and distributors. |
| Drug-delivery systems | 5% Related delivery components and packaging used with injectable therapies and syringe platforms. |
| Digital asset treasury activities | 5% Staking-related revenue from digital asset holdings and treasury operations. |
Sharps sells into healthcare channels that use syringes and injection-related products, including hospitals, clinics,...
- Hospitals and clinicsprimary
Buy disposable and safety syringes for routine patient care and injection workflows.
- Healthcare distributorsprimary
Purchase inventory for resale into healthcare channels and supply contracts.
- Healthcare providerssecondary
Use syringe products directly in clinical and specialty applications.
- Government buyerssecondary
Procure syringe products for public health and institutional supply needs.
- Medical supply organizationssecondary
Source syringe inventory and related products for distribution networks.
Sharps is headquartered in the United States and maintains a corporate office in Melville, New York...
- •United States is the corporate base and primary commercial market
- •Melville, New York is the company office location
- •Hungary hosts the Safegard syringe manufacturing facility
- •Products are marketed to domestic and international customers
- •Foreign employees and consultants support remote operations
Sharps is focused on commercializing its syringe platforms through manufacturing, inventory availability, and...
01
Commercialize syringe inventory and product linesshort-term
The company’s core value depends on converting designed and manufactured syringe products into repeatable sales.
02
Expand distribution platformmedium-term
Adding complementary third-party products can broaden the customer wallet share and reduce reliance on a narrow product set.
03
Maintain manufacturing and supply capabilityshort-term
Healthcare customers require dependable product availability and commercial quantities after orders are placed.
04
Build compliance and quality credibilitylong-term
Medical device distribution depends on FDA and international regulatory standards.
Sharps faces execution risk in commercializing a narrow syringe portfolio and in maintaining reliable supply, quality,...
Inventory and manufacturing risk
The business has built inventory and relies on commercial quantities being available quickly after orders are placed.
- Scope
- Syringe inventory and manufacturing operations
- Materiality
- high
Regulatory compliance risk
Medical device sales and distribution require compliance with FDA and international quality standards.
- Scope
- U.S. and foreign medical device markets
- Materiality
- high
Digital asset treasury risk
SOL holdings and staking revenue introduce price volatility, custody, and counterparty/operational risk.
- Scope
- Solana treasury strategy
- Materiality
- high
Trade policy and tariff risk
International sourcing and distribution can be affected by tariffs and trade restrictions.
- Scope
- Cross-border medical device operations
- Materiality
- medium
Revenue recognition
Affects reported sales timing and quarter-to-quarter comparability
Inventory reserve and net realizable value
Can reduce gross margin and increase expense recognition
Fair value of warrants and derivatives
Can create large non-cash gains or losses in earnings
Long-lived asset impairment
Can produce significant write-downs
Digital asset accounting
Affects balance sheet value and non-operating results
RETRACTABLE TECHNOLOGIES INC
RVP · Surgical & Medical Instruments & Apparatus
TELEFLEX INC
TFX · Surgical & Medical Instruments & Apparatus
REVVITY, INC.
RVTY · Laboratory Analytical Instruments
Revvity is a U.S.-based health science company that develops instruments, software, reagents, and services used across research, screening, diagnostics, and reproductive health workflows.
IR-Med, Inc.
Electromedical & Electrotherapeutic Apparatus
GLOBUS MEDICAL INC
GMED · Surgical & Medical Instruments & Apparatus
Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures.
STRYKER CORP
SYK · Surgical & Medical Instruments & Apparatus
: 29/04/2026